Large clinical trial funded by $3.5M federal research grant
Oct. 5, 2018
| By Susan Keown / Fred Hutch News Service
Dr. Mohamed Sorror has received a new five-year, $3.5 million grant from the National Cancer Institute to conduct a large clinical trial aimed at improving the quality of life and survival of medically vulnerable patients after they receive a transplant of donated blood-forming stem cells.
Mohamed Sorror-led study shows years play little role in patient outcomes following Center-developed 'mini-transplant'
Nov. 7, 2011
| By Dean Forbes
The first study summarizing long-term outcomes from a series of patients age 60 and over who were treated with the mini-transplant, a "kinder, gentler" form of transplantation developed at the Hutchinson Center, concluded that age alone no longer should be considered a defining factor when determining whether an older patient with blood cancer is a candidate for stem cell transplantation.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.